loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 40261 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ACETAMINOPHEN; BUTALBITAL; CAFFEINE (1)

filter

01 HIKMA (1)

filter

01 CAPSULE;ORAL (1)

filter

01 500MG;50MG;40MG (1)

filter

01 USA (1)

URL Supplier Web Content
CAPSULE;ORAL
500MG;50MG;40MG
BUTALBITAL, ACETAMINOP...
USA
40261
1998-10-28
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 40261

Looking for CTD TGA MCC DOSSIER APPLICATION 40261 1

19

Hikma Pharmaceuticals, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ACETAMINOPHEN; BUTALBITAL; CAFFEINE, with a corresponding application number 40261 and regulatory information .

proudly manufactured in the

approval since 1998-10-28

Hikma Pharmaceuticals's BUTALBITAL, ACETAMINOPHEN AND CAFFEINE CAPSULE;ORAL, medication with 500MG;50MG;40MG of ACETAMINOPHEN; BUTALBITAL; CAFFEINE.

Post Enquiry
POST ENQUIRY